Your browser doesn't support javascript.
loading
Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML).
Lu, Yu; Liu, Ying; Wen, Shupeng; Kuang, Na; Zhang, Xuejun; Li, Jianqiang; Wang, Fuxu.
Afiliação
  • Lu Y; Department of Hematology, Key Laboratory of Hematology of Hebei Province, Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Liu Y; Hebei Senlang Biotechnology Co, Shijiazhuang, China.
  • Wen S; Department of Hematology, Key Laboratory of Hematology of Hebei Province, Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Kuang N; Hebei Senlang Biotechnology Co, Shijiazhuang, China.
  • Zhang X; Department of Hematology, Key Laboratory of Hematology of Hebei Province, Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Li J; Hebei Senlang Biotechnology Co, Shijiazhuang, China. lijianqiang@senlangbio.com.
  • Wang F; Department of Hematology, Key Laboratory of Hematology of Hebei Province, Second Hospital of Hebei Medical University, Shijiazhuang, China. wfxhebmu@163.com.
J Transl Med ; 20(1): 600, 2022 12 14.
Article em En | MEDLINE | ID: mdl-36517851
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Revista: J Transl Med Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Revista: J Transl Med Ano de publicação: 2022 Tipo de documento: Article